These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1855097)

  • 21. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
    Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK
    Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fate of chronic myeloid leukemia patients treated with allogeneic bone marrow transplantation or chemotherapy and/or interferon at a single center: long-term results.
    Gaziev D; Galimberti M; Polchi P; Angelucci E; Giardini C; Baronciani D; Andreani M; Persini B; Erer B; Sodani P; Manna M; Nicolini G; Visani G; Lucarelli G;
    Bone Marrow Transplant; 2002 Jan; 29(1):1-8. PubMed ID: 11840137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized study of recombinant interleukin-2 after autologous bone marrow transplantation for acute leukemia in first complete remission.
    Blaise D; Attal M; Reiffers J; Michallet M; Bellanger C; Pico JL; Stoppa AM; Payen C; Marit G; Bouabdallah R; Sotto JJ; Rossi JF; Brandely M; Hercend T; Maraninchi D
    Eur Cytokine Netw; 2000 Mar; 11(1):91-8. PubMed ID: 10705305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children.
    Parsons SK; Castellino SM; Lehmann LE; Eickhoff CE; Tarbell NJ; Sallan SE; Weinstein HJ; Billett AL
    Bone Marrow Transplant; 1996 May; 17(5):763-8. PubMed ID: 8733695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
    Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
    Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hematopoietic stem cell transplantation for treatment of acute leukemia].
    Harada M
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1387-95. PubMed ID: 10500524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.
    de Lima M; van Besien KW; Giralt SA; Khouri IF; Mehra R; Andersson BS; Przepiorka D; Gajewski JL; Korbling M; Champlin RE
    Bone Marrow Transplant; 1997 Jan; 19(2):121-7. PubMed ID: 9116608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology.
    Aladjidi N; Auvrignon A; Leblanc T; Perel Y; Bénard A; Bordigoni P; Gandemer V; Thuret I; Dalle JH; Piguet C; Pautard B; Baruchel A; Leverger G;
    J Clin Oncol; 2003 Dec; 21(23):4377-85. PubMed ID: 14645428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Karyotype in acute myeloblastic leukemia: prognostic significance in a prospective study assessing bone marrow transplantation in first remission.
    Ferrant A; Doyen C; Delannoy A; Straetmans N; Martiat P; Mineur P; Bosly A; Van den Berghe H; Michaux JL
    Bone Marrow Transplant; 1995 May; 15(5):685-90. PubMed ID: 7670396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unrelated donor bone marrow transplantation using a chemotherapy-only preparative regimen for adults with high-risk acute myelogenous leukemia.
    Ayash LJ; Ratanatharathorn V; Braun T; Silver SM; Reynolds CM; Uberti JP
    Am J Hematol; 2007 Jan; 82(1):6-14. PubMed ID: 16986128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic bone marrow transplantation vs chemotherapy for children with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Sharathkumar A; Saunders EF; Dror Y; Grant R; Greenberg M; Weitzman S; Chan H; Calderwood S; Freedman MH; Doyle J
    Bone Marrow Transplant; 2004 Jan; 33(1):39-45. PubMed ID: 14566329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma.
    Harousseau JL; Attal M; Divine M; Milpied N; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M
    Bone Marrow Transplant; 1995 Jun; 15(6):963-9. PubMed ID: 7581098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role and perspectives of BMT in AML: the BFM experience.
    Klingebiel T; Ritter J; Schellong G; Creutzig U; Riehm H; Henze G; Bender-Götze C; Dopfer R; Ebell W; Friedrich W
    Bone Marrow Transplant; 1991; 7 Suppl 3():66-70. PubMed ID: 1855092
    [No Abstract]   [Full Text] [Related]  

  • 36. The additive risk model for estimation of effect of haplotype match in BMT studies.
    Scheike TH; Martinussen T; Zhang MJ
    Scand Stat Theory Appl; 2011 Sep; 38(3):409-423. PubMed ID: 21927531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the effects of a therapy by comparing the experience of currently treated and formerly treated patients.
    Weiss NS
    Epidemiology; 1999 Mar; 10(2):196-7. PubMed ID: 10069260
    [No Abstract]   [Full Text] [Related]  

  • 38. Apolipoprotein E isoforms, serum cholesterol, and cancer.
    Katan MB
    Lancet; 1986 Mar; 1(8479):507-8. PubMed ID: 2869248
    [No Abstract]   [Full Text] [Related]  

  • 39. The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19.
    Hoiland RL; Fergusson NA; Mitra AR; Griesdale DEG; Devine DV; Stukas S; Cooper J; Thiara S; Foster D; Chen LYC; Lee AYY; Conway EM; Wellington CL; Sekhon MS
    Blood Adv; 2020 Oct; 4(20):4981-4989. PubMed ID: 33057633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Evolution-Driven Signature of Parkinson's Disease.
    Diederich NJ; Uchihara T; Grillner S; Goetz CG
    Trends Neurosci; 2020 Jul; 43(7):475-492. PubMed ID: 32499047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.